Physiological regulation of the β-amyloid precursor protein signaling domain by c-Jun N-terminal kinase JNK3 during neuronal differentiation

被引:96
|
作者
Kimberly, WT
Zheng, JB
Town, T
Flavell, RA
Selkoe, DJ
机构
[1] Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA
来源
JOURNAL OF NEUROSCIENCE | 2005年 / 25卷 / 23期
关键词
amyloid precursor protein; AICD; JNK; Alzheimer's disease; phosphorylation; signaling mechanism;
D O I
10.1523/JNEUROSCI.4883-04.2005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
beta-Amyloid precursor protein (APP) is a conserved and ubiquitous transmembrane glycoprotein strongly implicated in the pathogenesis of Alzheimer's disease but whose normal biological function is unknown. Analogy to the Notch protein suggests that APP is a cell-surface receptor that signals via sequential proteolytic cleavages that release its intracellular domain (AICD) to the nucleus. Because these cleavages are major targets for therapeutic inhibition, it is critical to elucidate their physiological function. AICD is stabilized by Fe65, interacts with the transcriptional factor Tip60, and translocates to the nucleus. Here, we show that endogenous AICD in primary neurons is detectable only during a short period of time during differentiation in culture. During this transient rise, a portion of AICD localizes to the nucleus. Subsequently, phosphorylation of the APP cytoplasmic domain at threonine 668 appears to disrupt the stabilizing interaction with Fe65 and thus downregulate AICD-mediated signaling. Furthermore, we find that the neuron-specific c-Jun N-terminal kinase JNK3, but not JNK1 or JNK2, mediates a substantial portion of this phosphorylation. We conclude that endogenous AICD undergoes tight temporal regulation during the differentiation of neurons and is negatively regulated by JNK3 via phosphorylation of APP at Thr668.
引用
收藏
页码:5533 / 5543
页数:11
相关论文
共 50 条
  • [41] Characterization of a novel JNK (c-Jun N-terminal kinase) inhibitory peptide
    Ngoei, Kevin R. W.
    Catimel, Bruno
    Church, Nicole
    Lio, Daisy S.
    Dogovski, Con
    Perugini, Matthew A.
    Watt, Paul M.
    Cheng, Heung-Chin
    Ng, Dominic C. H.
    Bogoyevitch, Marie A.
    BIOCHEMICAL JOURNAL, 2011, 434 : 399 - 413
  • [42] C-Jun N-Terminal Kinase 2 (JNK2) In Sepsis
    Sala, M.
    Gu, L.
    Walter, J. M.
    Chen, C.
    Do-Umehara, H.
    Zhang, Q.
    Reyfman, P. A.
    Anekalla, K.
    Budinger, G. S.
    Misharin, A. V.
    Wunderink, R. G.
    Liu, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [43] The role of c-jun N-terminal kinase (JNK) in Parkinson's disease
    Peng, J
    Andersen, JK
    IUBMB LIFE, 2003, 55 (4-5) : 267 - 271
  • [44] The regulation of Bax by c-Jun N-terminal protein kinase (JNK) is a prerequisite to the mitochondrial-induced apoptotic pathway
    Papadakis, ES
    Finegan, KG
    Wang, X
    Robinson, AC
    Guo, C
    Kayahara, M
    Tournier, C
    FEBS LETTERS, 2006, 580 (05) : 1320 - 1326
  • [45] c-Jun N-terminal kinase (JNK) signaling contributes to cystic burden in polycystic kidney disease
    Smith, Abigail O.
    Jonassen, Julie A.
    Preval, Kenley M.
    Davis, Roger J.
    Pazour, Gregory J.
    PLOS GENETICS, 2021, 17 (12):
  • [46] Novel Tryptanthrin Derivatives with Selectivity as c-Jun N-Terminal Kinase (JNK) 3 Inhibitors
    Schepetkin, Igor A.
    Karpenko, Oleksander S.
    Kovrizhina, Anastasia R.
    Kirpotina, Liliya N.
    Khlebnikov, Andrei I.
    Chekal, Stepan I.
    Radudik, Alevtyna V.
    Shybinska, Maryna O.
    Quinn, Mark T.
    MOLECULES, 2023, 28 (12):
  • [47] Novel diaminopyrimidine inhibitors of c-Jun N-terminal kinase 3 (JNK3): SAR and ligand co-crystallization studies.
    Ma, V
    Tempest, PA
    Pettus, L
    Jona, J
    Henley, C
    Surapaneni, S
    Magal, E
    Powers, D
    Xie, YY
    Mohr, C
    Sun, Y
    Jordan, S
    Harte, B
    Hungate, R
    Hulme, C
    Meyer, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U197 - U197
  • [48] C-Jun N-terminal Kinase (JNK) Isoform 2 Augments Human Osteoblast Differentiation by Integrating Bone Morphogenetic Protein Signaling and Canonical Notch Signaling
    Wagley, Yadav
    Graham, Benjamin
    Hankenson, Kurt
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 328 - 328
  • [49] C-Jun N-terminal Kinase (JNK) Isoform 2 Augments Human Osteoblast Differentiation by Integrating Bone Morphogenetic Protein Signaling and Canonical Notch Signaling
    Wagley, Yadav
    Graham, Benjamin
    Hankenson, Kurt
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 47 - 47
  • [50] c-JUN N-terminal kinase-1 (JNK1) but not JNK2 or JNK3 is involved in UV signal transduction in human epidermis
    Katagiri, Chika
    Negishi, Kei
    Hibino, Toshihiko
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2006, 43 (03) : 171 - 179